Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2
Summary
To evaluate the safety and immunological effects of polyethylene glycolated-interleukin-2 (PEG-IL-2) on asymptomatic (without symptoms) HIV-seropositive patients who are taking zidovudine (AZT). To enhance measures of immune function with well-tolerated doses of PEG-IL-2, an immunomodulator, in a regimen designed to allow its use in outpatients with normal daily activity (i.e., full-time employment, etc.). Recombinant IL-2 (without PEG modification) was administered to HIV-infected patients by daily intradermal injection. At the low doses used, this was non-toxic, well-tolerated, and gave a systemic response as measured by natural killer cell and lymphokine-activated killer cell activity, but required daily administration. In the current study, the PEG modification of IL-2 is used since it has a much longer prolonged half-life compared with the non-PEG compound, without loss of functional activity.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Publications
- Background Teppler H, Montana A, Meyn P, Kaplan G, Cohn ZA. Prolonged immunostimulatory effect of low dose PEG interleukin-2 in HIV-infected individuals. Int Conf AIDS. 1992 Jul 19-24;8(2):B162 (abstract no PoB 3453)
- Zhang W, Ruan J, Zhang R, Zhang M, Hu X, Han Z, Ruan Q. Association between age-related hearing loss with tinnitus and cognitive performance in older community-dwelling Chinese adults. Psychogeriatrics. 2022 Nov;22(6):822-832. doi: 10.1111/psyg.12889. Epub 2022 Sep 8.
- Zhang W, Ruan J, Zhang R, Zhang M, Hu X, Yu Z, Han Z, Ruan Q. Age-Related Hearing Loss With Tinnitus and Physical Frailty Influence the Overall and Domain-Specific Quality of Life of Chinese Community-Dwelling Older Adults. Front Med (Lausanne). 2021 Oct 21;8:762556. doi: 10.3389/fmed.2021.762556. eCollection 2021.
- Ruan Q, Chen J, Zhang R, Zhang W, Ruan J, Zhang M, Han C, Yu Z. Heterogeneous Influence of Frailty Phenotypes in Age-Related Hearing Loss and Tinnitus in Chinese Older Adults: An Explorative Study. Front Psychol. 2021 Feb 16;11:617610. doi: 10.3389/fpsyg.2020.617610. eCollection 2020.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PEG IL-2 | Unknown | — | Intrathecal |